TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $580 | +35.5% | 37,477 | +37.7% | 0.01% | +28.6% |
| Q2 2023 | $428 | +2.9% | 27,222 | +7.9% | 0.01% | 0.0% |
| Q1 2023 | $416 | -99.9% | 25,221 | +5.3% | 0.01% | 0.0% |
| Q4 2022 | $374,000 | -99.9% | 23,953 | +17.2% | 0.01% | +40.0% |
| Q3 2022 | $265,000,000 | +98048.1% | 20,446 | +6.2% | 0.01% | 0.0% |
| Q2 2022 | $270,000 | +21.1% | 19,249 | +23.9% | 0.01% | +25.0% |
| Q1 2022 | $223,000 | -99.9% | 15,541 | +22.9% | 0.00% | +33.3% |
| Q4 2021 | $172,000,000 | +84629.1% | 12,648 | +2.3% | 0.00% | -25.0% |
| Q3 2021 | $203,000 | -5.1% | 12,368 | -2.6% | 0.00% | -20.0% |
| Q2 2021 | $214,000 | -5.3% | 12,704 | +2.8% | 0.01% | 0.0% |
| Q1 2021 | $226,000 | +14.7% | 12,360 | +14.2% | 0.01% | 0.0% |
| Q4 2020 | $197,000 | – | 10,821 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |